Cargando…
Negatively charged AuNP modified with monoclonal antibody against novel tumor antigen FAT1 for tumor targeting
BACKGROUND: Herein, we demonstrated the use of a newly generated anti FAT1 antibody (clone mAB198.3) for intracellular delivery of anionic gold NPs, to form active targeting Au nanoparticles with high payload characteristics. METHODS: In vitro characterizations were determined by DLS, confocal micro...
Autores principales: | Fan, Li, Campagnoli, Susanna, Wu, Hong, Grandi, Alberto, Parri, Matteo, De Camilli, Elisa, Grandi, Guido, Viale, Giuseppe, Pileri, Piero, Grifantini, Renata, Song, Chaojun, Jin, Boquan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4570718/ https://www.ncbi.nlm.nih.gov/pubmed/26373379 http://dx.doi.org/10.1186/s13046-015-0214-x |
Ejemplares similares
-
FAT1: a potential target for monoclonal antibody therapy in colon cancer
por: Pileri, Piero, et al.
Publicado: (2016) -
ERMP1, a novel potential oncogene involved in UPR and oxidative stress defense, is highly expressed in human cancer
por: Grandi, Alberto, et al.
Publicado: (2016) -
TCTN2: a novel tumor marker with oncogenic properties
por: Cano-Rodriguez, David, et al.
Publicado: (2017) -
AuNP Aptasensor for Hodgkin Lymphoma Monitoring
por: Slyusarenko, Maria, et al.
Publicado: (2022) -
Crystalline AuNP-Decorated
Strontium Niobate Thin
Films: Strain-Controlled AuNP Morphologies and Optical Properties
for Plasmonic Applications
por: Yao, Qiaomu, et al.
Publicado: (2023)